Message from the President
The International Society for Stem Cell Research (ISSCR) today released the following statement regarding Google’s new policy that bans advertisements from unproven stem cell clinics and other speculative medical interventions.Full story
- 6 September, 2019
The International Society for Stem Cell Research (ISSCR) today released a professional standard of informed consent for stem cell-based interventions performed outside of formal clinical trials, such as the unapproved and unproven “treatments” offered by clinicians at direct-to-consumer clinics. The standard is meant to help ensure that patients are informed about the potential benefits and risks of stem cell-based medical interventions, and was developed with input from clinicians, ethicists, researchers, and regulators from around the world.Full story
- 12 August, 2019
Gladstone Institutes, U.S.
Don’t Believe Everything You Hear about Stem Cells
Although stem cell science is progressing rapidly, bad actors have co-opted stem cells’ hope and promise by preying on unsuspecting patients and their families. In a recent article in Scientific American, ISSCR President Deepak Srivastava outlines specific claims that should raise red flags for patients and their families.
stem cell researchTake a closer look
Injured or misled by unscrupulous stem cell clinics? Here’s what you can do about it.
Have you come across an ad informing you that stem cells can cure your [insert disease/condition here]? These marketing claims made by so-called “stem cell" clinics are everywhere. In reality, there are currently very few stem cell treatments that are proven both safe and effective and/or approved by regulatory authorities. This month's ISSCR blog explains what you can do to report false marketing claims or adverse events from clinics offering unproven stem cell "therapies."
Stem Cells in the News
Media highlights in the field of stem cell research and its translation to the clinic.
8 August, Stem Cell Xpress
CRISPR Gene Editing Is Being Tested in Human Patients, and the Results Could Revolutionize Health Care
6 August, Time
3 August, The Guardian
A sampling of recent stem cell research commentaries, articles, and resources.
On the cover: Stepwise transduction of iPSC-derived pancreatic progenitor cells by three transcription factors, PDX1, NEUROG3, and MAFA, enabled in vitro generation of glucose- and GLP-1-responsive beta cells. ''Forward reprogrammed'' iPSC-derived islet-like cells were analyzed by immunofluorescent staining for insulin (green) and NKX2.2 (red) expression.
Featured Current Protocols in Stem Cell Biology Article
A High-Throughput Screening Method to Identify Compounds Displaying Human Vascular Embryonic Toxicity, Rose et al. (2019), Current Protocols in Stem Cell Biology, 50, e93. doi: 10.1002/cpsc.93.
Induced 2C Expression and Implantation-Competent Blastocyst-Like Cysts From Primed Pluripotent Stem Cells, Kime et al (2019), Stem Cell Reports. doi:10.1016/j.stemcr.2019.07.011.
Seeking a job? Have a job opening? the ISSCR Job Board gives members discounts on job postings here and in the monthly Pulse e-newsletter.
Other Stem Cell Events
Opportunities for researchers from around the world to explore the latest discoveries in stem cell science and regenerative medicine.
Global Policy News
ISSCR and policy news from around the world.
25 July, Regulatory Focus
As Stem Cell Clinics Proliferate, Energy and Commerce Leaders Seek to Hear FDA’s Plan
26 July, Science
Trump Administration Releases Details on Fetal Tissue Restrictions
3 August, The Guardian
FDA First Human-Monkey Chimera Raises Concern Among Scientists
Learn about ISSCR colleagues in the stem cell field from around the world.
Dennis Clegg, PhD
Santa Barbara, CA, USA
PhD, University of California, Berkeley, USA
Professor, University of California, Santa Barbara, USA